Welcome to AMIGOs

Australasian Merkel Cell Carcinoma Interest Group

“Enabling access to high quality care for all patients with Merkel Cell Carcinoma”

What is Merkel Cell Carcinoma?

Merkel Cell Carcinoma is a rare but highly aggressive neuroendocrine skin cancer.

Merkel Cell Carcinoma has the potential to be lethal and appropriate management should be sought immediately through a specialist centre.
Treatment often will involve several types of therapy such as surgery, radiation, and sometimes systemic medications. Multidisciplinary evaluation of patients with this cancer is critical to determine and carry out a proper treatment plan.

“Many patients and primary care doctors don’t understand the severity of a Merkel Cell Carcinoma diagnosis. Carers and families often don’t appreciate the seriousness of the condition. How could a skin cancer that you have never heard of, give you a deadly problem, unless it is malignant melanoma? Merkel Cell Carcinoma patients need quick referral to specialists at centres of excellence who understand this disease.”

Jonathan Pincus
Chair, Patient Advocacy Group

Jonathan Pincus


We're pleased to announce the appointment of Cheryl-Ann Hawkins as CEO of MASC Trials. Cheryl-Ann's decorated 30-year career spans various leadership oncology nursing roles with a focus on early phase/first in human drug trials. Read more: https://t.co/CRIij5J8YS

This Clinical Trials Day we salute the people who make these trials possible through their hard work & dedication. Every new participant is another step towards improving outcomes & quality of life for #SkinCancer & #Melanoma patients around the world 🌎 #CTD2021 #ClinicalTrials


The latest podcast from @MelanomaAus discusses the multidisciplinary management of #merkelcellcarcinoma. Listen on your favourite #podcast app or on the Melanoma Education Portal: https://t.co/3JPZqKW7SV @KerwinFShannon @inespiresilva @AngelaHong

Load More...